Germany Cardiac Biomarker Market: Global Size, Industry Trends, Leading Players, Share and Forecast 2019-2025


Posted January 22, 2020 by orionmarketresearch

Germany Cardiac biomarker Market Size, Share & Trends Analysis Report by Type, By Application, By Location of Testing and Forecast 2019-2025
 
Germany Cardiac Biomarker Market is estimated to grow significantly at a CAGR of around 7.5% during the forecast period. The market mainly is driven due to due to the massive population of CVD, CHD &stroke and rise in adoption of a cardiac biomarker for the diagnosis of CVD and other heart related diseases. The demand for cardiac biomarker tests for Myocardial infarction, Acute coronary syndrome, and heart failure are increasing significantly and boosting the market growth. According to the Global Burden of Disease database, Germany accounted for more about 1.03 million new cases of CVD in 2010 that increased to about 1.08 million in 2015. Adoption of specialized procedures to treat CVDs such as biomarkers, extensive R&D in the CVDs diagnosis and presence of globally renowned major hospitals, research centers and clinics are contributing to the growth of the market.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/germany-cardiac-biomarker-market

The market is segmented on the basis of type, application, and location of testing. Based on type, the market is segregated into Creatine kinase (CK-MB), Troponins (T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others. The troponin is anticipated to be the fastest growing and has a considerable market share in the Germany cardiac biomarker market due to easy and high sensitivity that results in the high adoption of the test. Based on application, the market is segmented into myocardial infraction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. On the basis of the location of testing, the market is classified into laboratory testing and point of care testing.

A full report of Germany Cardiac Biomarker Market is available at: https://www.omrglobal.com/industry-reports/germany-cardiac-biomarker-market

Germany Cardiac Biomarker Market Segmentation

by Type

• Creatine kinase (CK-MB)
• Troponins (T, I)
• Myoglobin
• Natriuretic peptides (BNP & NT-PROBNP)
• Ischemia modified albumin
• Others

by Application

• Myocardial infraction
• Congestive heart failure
• Acute coronary syndrome
• Atherosclerosis
• Others

by Location of Testing

• Laboratory testing
• Point of care testing

Company Profiles

• Abbott Laboratories
• BioMérieux S.A.
• Cisbio Bioassays SAS
• Danaher Corp.
• F. Hoffmann-La Roche AG
• HyTest Ltd
• Merck KGaA
• Randox Laboratories Ltd.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Arti Sharma
Phone 07803040404
Business Address 305-308, Commerce House, Janjeerwala Square
Country India
Categories Biotech , News , Technology
Tags biotechnology , healthcare
Last Updated January 22, 2020